What are Mitochondrial myopathies?
Mitochondrial myopathies are a group of neuromuscular diseases
caused by damage to the mitochondria-small, energy-producing
structures found in every cell in the body that serve as the cells'
"power plants." Nerve cells in the brain and muscles require a great
deal of energy, and thus appear to be particularly damaged when
mitochondrial dysfunction occurs.
Some of the more common mitochondrial
myopathies include Kearns-Sayre syndrome, myoclonus epilepsy with
ragged-red fibers, and mitochondrial encephalomyopathy with lactic
acidosis and stroke-like episodes. The symptoms of
mitochondrial myopathies include muscle weakness or exercise
intolerance, heart failure or rhythm disturbances, dementia,
movement disorders, stroke-like episodes, deafness, blindness,
droopy eyelids, limited mobility of the eyes, vomiting, and
seizures.
The prognosis for these disorders ranges in
severity from progressive weakness to death. Most mitochondrial
myopathies occur before the age of 20, and often begin with exercise
intolerance or muscle weakness. During physical activity, muscles
may become easily fatigued or weak. Muscle cramping is rare, but may
occur. Nausea, headache, and breathlessness are also associated with
these disorders.
Is there any treatment?
Although there is no specific treatment for any of the mitochondrial
myopathies, physical therapy may extend the range of movement of
muscles and improve dexterity. Vitamin therapies such as
riboflavin, coenzyme Q, and carnitine (a specialized amino acid) may provide subjective improvement in fatigue and energy
levels in some patients.
What is the prognosis?
The prognosis for patients with mitochondrial myopathies varies
greatly, depending largely on the type of disease and the degree of
involvement of various organs. These disorders cause progressive
weakness and can lead to death.